EUVIMEDEUVIMED entdecken
Crossref

Prevalence of Polycystic Ovarian Syndrome in Young and Adolescent Transmasculine Patients Presenting for Gender-Affirming Care

Sabrina K Rangi, Jenna Rehmer, Cecile A Ferrando

Journal of Pediatric and Adolescent Gynecology · 2024

DOI: 10.1016/j.jpag.2023.09.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric and Adolescent Gynecology, 2024. Verfasst von Sabrina K Rangi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic, Department of Obstetrics and Gynecology, Women's Health Institute, Cleveland, Ohio. Electronic address: rangis2@ccf.org. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Hyperandrogenism. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

STUDY OBJECTIVE: To determine the incidence of polycystic ovarian syndrome (PCOS) and hyperandrogenism among adolescent transmasculine patients presenting to a tertiary care referral center for gender-affirming care METHODS: This was a retrospective study of adolescent transmasculine patients presenting to Cleveland Clinic for gender-affirming hormone therapy. The diagnostic criteria were adolescent-specific as defined by the international evidence-based guideline for PCOS management and included oligomenorrhea and/or anovulation with clinical and/or biochemical hyperandrogenism after exclusion of other androgen excess disorders. RESULTS: The described transgender population had a prevalence of PCOS of 23.8%. The transmasculine patients who met the criteria for PCOS had both higher levels of androgens and higher body mass indexes when compared with the patients without PCOS. Additionally, the patients with PCOS had higher rates of dyslipidemia. CONCLUSION: The prevalence of PCOS among transmasculine patients may be higher compared with the general population. Transmasculine patients with PCOS should be counseled regarding the long-term health implications associated with PCOS and screened appropriately to minimize risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeHyperandrogenismFemaleHumansAdolescentRetrospective StudiesPrevalenceGender-Affirming Care

Stichwörter der Autor:innen

HyperandrogenismPolycystic ovarian syndromeTransgender persons

Autor:innen und Institutionen

  • Cleveland Clinic, Department of Obstetrics and Gynecology, Women's Health Institute, Cleveland, Ohio. Electronic address: rangis2@ccf.org.
  • Cleveland Clinic, Department of Obstetrics and Gynecology, Women's Health Institute, Cleveland, Ohio.

Zitieren

APA

Rangi, S. K., Rehmer, J., & Ferrando, C. A. (2024). Prevalence of Polycystic Ovarian Syndrome in Young and Adolescent Transmasculine Patients Presenting for Gender-Affirming Care. Journal of Pediatric and Adolescent Gynecology. https://doi.org/10.1016/j.jpag.2023.09.003

Vancouver

Rangi SK, Rehmer J, Ferrando CA. Prevalence of Polycystic Ovarian Syndrome in Young and Adolescent Transmasculine Patients Presenting for Gender-Affirming Care. Journal of Pediatric and Adolescent Gynecology. 2024. doi:10.1016/j.jpag.2023.09.003

BibTeX
@article{Rangi2024,
  author = {Rangi, Sabrina K and Rehmer, Jenna and Ferrando, Cecile A},
  title = {Prevalence of Polycystic Ovarian Syndrome in Young and Adolescent Transmasculine Patients Presenting for Gender-Affirming Care},
  journal = {Journal of Pediatric and Adolescent Gynecology},
  year = {2024},
  doi = {10.1016/j.jpag.2023.09.003}
}
Kostenlos starten →